What Changes on November 12? The First Federal Hemp Date, Explained for Florida Dispensaries [2026]

On Thursday, November 12, 2026, one narrow piece of the new federal hemp definition is set in statute to take effect: hemp-derived products containing cannabinoids "not capable of being naturally produced by a Cannabis sativa L. plant" stop counting as hemp. Everything else in the law — the total-THC test, the 0.4 mg per-container cap, and cannabinoids the plant can make but that were "synthesized or manufactured outside the plant" — is set for Friday, December 11, unless Congress moves it again.

As we read Florida law, November 12 doesn't change what a Florida medical marijuana treatment center is allowed to sell. It may change what customers ask at your counter. Here's what the law actually says, the gap in it, and what to do that week.

What the law says takes effect November 12

The hemp rewrite is Section 781 of Public Law 119-37, enacted November 12, 2025 and written to take effect "365 days after the enactment of this Act." It excludes from the definition of hemp any final hemp-derived cannabinoid product containing:

• "cannabinoids that are not capable of being naturally produced by a Cannabis sativa L. plant";
• cannabinoids that "are capable of being naturally produced by a Cannabis sativa L. plant" and "were synthesized or manufactured outside the plant"; or
• "greater than 0.4 milligrams combined total per container" of total THC and similarly acting cannabinoids.

The same three exclusions apply to intermediate products, with a 0.3 percent limit in place of the per-container cap.

In September, Congress moved most of that back a month. Section 2019 of P.L. 119-103 (H.R. 6500), signed September 2, says that until December 11, 2026, the hemp amendments "shall only apply with respect to products described in paragraphs (1)(C)(ii)(I) and (1)(C)(iv)(I)" — the two "not capable of being naturally produced" clauses, one for intermediate products and one for final products. So:

Date (set in statute)	What takes effect
Thu, Nov 12	Products containing cannabinoids "not capable of being naturally produced" by the plant lose federal hemp status
Fri, Dec 11	Everything else: the total-THC definition, the 0.4 mg per-container cap, and naturally producible cannabinoids synthesized or manufactured outside the plant

What losing hemp status means: according to the Congressional Research Service's September 28 update, "Starting November 12, 2026, cannabis products that fit within this exclusion are to be classified as marijuana under the CSA" — the federal Controlled Substances Act.

Which products? The list Congress asked for doesn't exist yet

The statute told the FDA to publish, within 90 days, "a list of all cannabinoids known to FDA to be capable of being naturally produced by a Cannabis sativa L. plant, as reflected in peer reviewed literature" (P.L. 119-37, §781(3)). That deadline passed in February. As of CRS's September 28 update, "such a list has not been published," and we found no published list as of October 12.

Without it, which products fall in the November category comes down to earlier agency positions and how lawyers read them:

• THC-O is the clearest case. Per a CRS legal sidebar, THC-O "does not occur naturally in the cannabis plant, so DEA took the position that THCO did not qualify" as hemp — though the same sidebar notes that "one federal appeals court held that THCO fell within the 2018 farm bill's definition of hemp."
• HHC is another case some lawyers name. DEA's May 2026 final rule calls it "a synthetic substance that is structurally related to tetrahydrocannabinols." A company has petitioned the Fourth Circuit to review that rule (argument was heard September 18), and HHC has long been "claimed by many to be naturally occurring in trace amounts" — a claim Cannabis Business Times noted "has not been proven by peer-reviewed research."
• Delta-8 and delta-10, in our reading, are not in the November group. CRS notes they "occur in the cannabis plant in small amounts" and "can also be synthesized from other cannabinoids" — and naturally producible cannabinoids made outside the plant are exactly the category the delay pushed to December 11. Frier Levitt, for one, gives "delta-8 THC derived through CBD isomerization" as its example of that category.

Treat everything past THC-O as unsettled. If the FDA list appears before November 12, it would be the clearest federal signal of which cannabinoids fall in the November group.

In Florida, the clearest November case was already treated as controlled

Florida's agriculture department has treated THC-O as a controlled substance for years. In 2023, the Florida Department of Agriculture and Consumer Services announced a seizure of hemp extract products containing THC-O, which it described as "categorized as a controlled substance under federal and state law, §893.03(1)(c)190, Fla. Stat." Florida's own hemp statute, §581.217, sets its own definition and an age-21 sales rule; the federal date doesn't amend it.

And the November change doesn't reach an MMTC's shelf. Florida's MMTC statute, §381.986, says a treatment center "may not dispense or sell any other type of cannabis, alcohol, or illicit drug-related product," other than "a marijuana delivery device required for the medical use of marijuana and which is specified in a physician certification." As we read it, nothing an MMTC sells is a federal "hemp" product to begin with. Confirm with your own counsel.

So for a Florida MMTC, we expect November 12 to be a small date. The main thing it's likely to change is what customers ask after reading "hemp ban" headlines.

What to do the week of November 12

Brief your staff with accurate answers. The questions will be "is THC banned now?" and "do you sell what the gas station stopped selling?" The accurate answers: November 12 covers a narrow set of hemp products made with cannabinoids the plant isn't capable of producing naturally; most hemp THC products are on the December 11 date; a Florida dispensary sells medical marijuana to qualified patients, and here's how the medical program works. Keep it to patient education — not legal advice, and not a pitch to swap one product for another.

Keep December 11 as your campaign date. Our December 11 countdown playbook treats November 12 as the dress rehearsal: switch on the patient-education rotation on your interior screens, see what new visitors ask about, and fix what's clumsy while the stakes are small. Florida's rules still govern every screen — interior-facing, qualified-patient framing, through your normal compliance review (our read of the marketing rules).

Watch three things before December 11:

1. The FDA list. If it's published, it would be the clearest federal signal of which cannabinoids are in the November group.
2. Congress. CRS lists bills that would delay the new definition by two more years (H.R. 7024, H.R. 7010, S. 3686), repeal it (H.R. 6209), or build a federal regulatory framework instead (H.R. 7212, H.R. 9830, H.R. 10079, S. 3474) — all described as introduced bills in its September 28 update.
3. December 11 itself. The same law, P.L. 119-103 (H.R. 6500), funds the government only through that date, so the hemp deadline and the next funding fight arrive together.

The short version

November 12 is the small date. It is set to remove hemp status from products containing cannabinoids "not capable of being naturally produced" by the plant — THC-O most clearly — while the larger change is set for December 11. In Florida, the clearest example, THC-O, was already treated as a controlled substance by the state's agriculture department, and as we read Florida law, an MMTC's shelf doesn't change. What does change is the conversation at your counter, so get the answers right and use the week to test your December campaign.

If you'd rather flip a patient-education rotation on across every screen in every store on a set date than reprint signage twice, that's what we do. See how GreenScreens works, or book a demo and we'll show you a live store. Choosing screens for the first time? Start with the dispensary digital signage buyer's guide. Every Florida date in this series is on one page: the Florida compliance hub.

Related reading: The December 11 countdown playbook · The hemp THC ban and the customers coming back · Florida's Q4 2026 compliance calendar

This post describes federal and Florida law as published through October 12, 2026, and is not legal advice. Statutory text is quoted from govinfo.gov and flsenate.gov; agency positions from the Congressional Research Service, DEA, and FDACS as linked. The FDA cannabinoid list required by P.L. 119-37 had not been published as of that date; if it is, this post will be updated.